Optic neuritis: symptoms and treatment

Optic neuritis is an inflammatory condition affecting the optic nerve, which transmits visual information from the eye to the brain. In this condition, the myelin sheath, a protective covering around the nerve fibers, becomes damaged due to inflammation. This damage disrupts the electrical signals traveling along the nerve, leading to impaired vision. Understanding this inflammatory mechanism is crucial for comprehending the symptoms and guiding appropriate treatment strategies.

Optic neuritis can sometimes occur without a clear identifiable cause (idiopathic). However, it is frequently a manifestation of underlying systemic or autoimmune diseases. Common conditions associated with optic neuritis include multiple sclerosis (MS), neuromyelitis optica (NMO), and MOG antibody associated disease. Multiple sclerosis is a particularly prevalent cause, with many individuals affected by MS experiencing optic neuritis at least once. Identifying the underlying cause is essential for determining the most effective treatment and long term management plan.

Key symptoms of optic neuritis include a reduction in visual acuity, blurred or dimmed vision, and alterations in color perception and contrast sensitivity. Visual impairment may temporarily worsen with physical activity or an increase in body temperature, a phenomenon known as Uhthoff's phenomenon. Additionally, many patients report eye pain, which typically intensifies with eye movement. This pain results from the stretching of the inflamed optic nerve by the muscles that move the eye.

Diagnosis is performed by a neuro ophthalmologist and involves a comprehensive eye examination and assessment of visual functions. This includes evaluating visual acuity, color vision, contrast sensitivity, and visual fields. Depending on the clinical findings, further diagnostic tests may be required. These can include a brain and orbital MRI scan, blood tests to identify specific antibodies, and in some cases, a lumbar puncture. These tests help pinpoint the cause of the inflammation and assess the risk of associated conditions, such as multiple sclerosis.

In typical optic neuritis, often associated with multiple sclerosis, vision may improve without treatment. High dose steroids can speed recovery but usually do not improve the final visual result in this typical form. The decision depends on the severity, examination, test results and the patient's overall health. Steroids may affect blood pressure, blood sugar and mood, among other risks.

Atypical optic neuritis needs a different approach. Conditions such as NMO or MOG associated disease may need urgent high dose steroids and sometimes plasma exchange to protect vision, as well as longer term treatment to reduce further attacks. If infection is the cause, specific treatment of the infection is essential. Treatment must therefore be directed at the identified or suspected cause under specialist care, rather than assuming every case will recover on its own.

Most patients with typical optic neuritis experience significant visual improvement, often returning close to their baseline vision within several weeks, with or without treatment. However, in cases where the cause is NMO, infection, or other inflammatory processes, the prognosis may be less favorable, potentially requiring more aggressive immunosuppressive therapies. Approximately one third of patients may experience a recurrent episode of optic neuritis, either in the same eye or the other eye. Therefore, regular medical follow up is important to assess recovery and to promptly identify recurrences or the development of associated diseases.

It is crucial to seek prompt medical evaluation for any new, sudden, or progressive decrease in vision, eye pain accompanied by visual changes, or any new neurological symptoms. Early diagnosis and treatment can influence the course of the condition and the chances of recovery. Medical follow up is individualized by a neuro ophthalmologist and neurologist, based on the cause of the inflammation, its severity, and the response to treatment, including periodic assessment of visual functions and overall neurological status.